# A Phase I Study of SHR1459 in Healthy Subjects

> **NCT04455100** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 20 (actual)

## Conditions studied

- Health, Subjective

## Interventions

- **DRUG:** SHR1459/Itraconazole

## Key facts

- **NCT ID:** NCT04455100
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-17
- **Primary completion:** 2020-08-14
- **Final completion:** 2020-08-14
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04455100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04455100, "A Phase I Study of SHR1459 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04455100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*